{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:58:39Z","timestamp":1772121519360,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI12\/01135 to JMZ and PI13\/00789 to CdR"],"award-info":[{"award-number":["PI12\/01135 to JMZ and PI13\/00789 to CdR"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Economia y Competitividad","doi-asserted-by":"publisher","award":["SAF2011-23846"],"award-info":[{"award-number":["SAF2011-23846"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.phrs.2014.08.005","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T20:15:46Z","timestamp":1409429746000},"page":"46-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein\u2013Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines"],"prefix":"10.1016","volume":"89","author":[{"given":"Gema","family":"Perez-Chacon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristobal","family":"de los Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan M.","family":"Zapata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2014.08.005_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mrrev.2011.06.001","article-title":"Attenuation of multi-targeted proliferation-linked signaling by 3,3\u2032-diindolylmethane (dim): From bench to clinic","volume":"728","author":"Banerjee","year":"2011","journal-title":"Mutat Res"},{"key":"10.1016\/j.phrs.2014.08.005_bib0010","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4161\/cc.4.9.1993","article-title":"Molecular targets and anticancer potential of indole-3-carbinol and its derivatives","volume":"4","author":"Aggarwal","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phrs.2014.08.005_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2008.01.033","article-title":"Indole-3-carbinol as a chemopreventive and anti-cancer agent","volume":"262","author":"Weng","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.phrs.2014.08.005_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jnutbio.2004.10.007","article-title":"Targets for indole-3-carbinol in cancer prevention","volume":"16","author":"Kim","year":"2005","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.phrs.2014.08.005_bib0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1182\/blood-2004-12-4589","article-title":"Indole-3-carbinol suppresses nf-kappab and ikappabalpha kinase activation, causing inhibition of expression of nf-kappab-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells","volume":"106","author":"Takada","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2014.08.005_bib0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0009-2797(91)90090-T","article-title":"Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro","volume":"80","author":"De Kruif","year":"1991","journal-title":"Chemico-Biol Interact"},{"key":"10.1016\/j.phrs.2014.08.005_bib0035","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1158\/1055-9965.EPI-06-0396","article-title":"Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3\u2032-diindolylmethane","volume":"15","author":"Reed","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.phrs.2014.08.005_bib0040","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1158\/1055-9965.EPI-05-0121","article-title":"A phase I study of indole-3-carbinol in women: tolerability and effects","volume":"14","author":"Reed","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.phrs.2014.08.005_bib0045","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1158\/1078-0432.CCR-04-0163","article-title":"Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice","volume":"10","author":"Anderton","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.phrs.2014.08.005_bib0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/dmd.32.6.632","article-title":"Physiological modeling of formulated and crystalline 3,3\u2032-diindolylmethane pharmacokinetics following oral administration in mice","volume":"32","author":"Anderton","year":"2004","journal-title":"Drug Metabol Disposition: Biol Fate Chem"},{"key":"10.1016\/j.phrs.2014.08.005_bib0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1753-4887.2007.tb00303.x","article-title":"A review of the clinical efficacy and safety of cruciferous vegetable phytochemicals","volume":"65","author":"Minich","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.phrs.2014.08.005_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.2000.5847","article-title":"Placebo-controlled trial of indole-3-carbinol in the treatment of cin","volume":"78","author":"Bell","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0196-0709(97)90012-0","article-title":"Treatment of recurrent respiratory papillomatosis with indole-3-carbinol","volume":"18","author":"Coll","year":"1997","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0070","first-page":"4569","article-title":"Estrogen metabolism and laryngeal papillomatosis: a pilot study on dietary prevention","volume":"18","author":"Auborn","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.phrs.2014.08.005_bib0075","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0194-5998(98)70274-8","article-title":"Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis","volume":"118","author":"Rosen","year":"1998","journal-title":"Otolaryngology \u2013 Head Neck Surg"},{"key":"10.1016\/j.phrs.2014.08.005_bib0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nrmicro2015","article-title":"The curious case of the tumour virus: 50 years of Burkitt's lymphoma","volume":"6","author":"Thorley-Lawson","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MOH.0b013e3281bccdee","article-title":"Biology and treatment of Burkitt's lymphoma","volume":"14","author":"Yustein","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0090","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","article-title":"Aggressive b-cell lymphomas: a review of new and old entities in the who classification","volume":"2011","author":"Jaffe","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.phrs.2014.08.005_bib0095","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/CCO.0b013e32832f3dcd","article-title":"Lessons from clinical trials in African Burkitt lymphoma","volume":"21","author":"Magrath","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4049\/jimmunol.1200814","article-title":"Tnfr-associated factor 2 deficiency in b lymphocytes predisposes to chronic lymphocytic leukemia\/small lymphocytic lymphoma in mice","volume":"189","author":"Perez-Chacon","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0105","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1073\/pnas.0509988103","article-title":"Three restricted forms of Epstein\u2013Barr virus latency counteracting apoptosis in c-myc-expressing burkitt lymphoma cells","volume":"103","author":"Kelly","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2014.08.005_bib0110","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1158\/1078-0432.CCR-10-2578","article-title":"Epstein\u2013Barr virus-associated b-cell lymphomas: pathogenesis and clinical outcomes","volume":"17","author":"Saha","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.phrs.2014.08.005_bib0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.mrfmmm.2013.07.007","article-title":"Double strand break repair functions of histone h2ax","volume":"750","author":"Scully","year":"2013","journal-title":"Mutat Res"},{"key":"10.1016\/j.phrs.2014.08.005_bib0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbagrm.2012.02.021","article-title":"Gamma-h2ax and other histone post-translational modifications in the clinic","volume":"1819","author":"Redon","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2014.08.005_bib0125","doi-asserted-by":"crossref","first-page":"39108","DOI":"10.1074\/jbc.M110.151753","article-title":"Mst1 promotes apoptosis through phosphorylation of histone h2ax","volume":"285","author":"Wen","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2014.08.005_bib0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/aps.2012.9","article-title":"Imatinib induces h2ax phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3\/mst1 pathway","volume":"33","author":"Zhang","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.phrs.2014.08.005_bib0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/carcin\/bgl171","article-title":"Egfr and src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells","volume":"28","author":"Moiseeva","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phrs.2014.08.005_bib0140","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1128\/MCB.24.19.8541-8555.2004","article-title":"Direct repression of flip expression by c-myc is a major determinant of trail sensitivity","volume":"24","author":"Ricci","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0145","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1158\/0008-5472.CAN-08-4617","article-title":"E2f1 expression is deregulated and plays an oncogenic role in sporadic burkitt's lymphoma","volume":"69","author":"Molina-Privado","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.phrs.2014.08.005_bib0150","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1038\/leu.2012.99","article-title":"E2f4 plays a key role in burkitt lymphoma tumorigenesis","volume":"26","author":"Molina-Privado","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.phrs.2014.08.005_bib0155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tim.2003.09.009","article-title":"Epstein\u2013Barr virus, the tcl-1 oncogene and Burkitt's lymphoma","volume":"11","author":"Bell","year":"2003","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0160","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1182\/blood-2006-12-064865","article-title":"Gene-expression analysis identifies novel rbl2\/p130 target genes in endemic burkitt lymphoma cell lines and primary tumors","volume":"110","author":"De Falco","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2014.08.005_bib0165","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/v4091537","article-title":"Contributions of Epstein\u2013Barr nuclear antigen 1 (ebna1) to cell immortalization and survival","volume":"4","author":"Frappier","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.phrs.2014.08.005_bib0170","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1093\/nar\/gkt032","article-title":"The Epstein\u2013Barr virus nuclear antigen-1 reprograms transcription by mimicry of high mobility group a proteins","volume":"41","author":"Coppotelli","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.phrs.2014.08.005_bib0175","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1038\/sj.onc.1208779","article-title":"Nfkb 1 is dispensable for myc-induced lymphomagenesis","volume":"24","author":"Keller","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2014.08.005_bib0180","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1079\/BJN2003917","article-title":"Development of a food composition database for the estimation of dietary intakes of glucosinolates, the biologically active constituents of cruciferous vegetables","volume":"90","author":"McNaughton","year":"2003","journal-title":"Br J Nutr"},{"key":"10.1016\/j.phrs.2014.08.005_bib0185","first-page":"441","article-title":"Review Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer","volume":"22","author":"Bradlow","year":"2008","journal-title":"In Vivo"},{"key":"10.1016\/j.phrs.2014.08.005_bib0190","first-page":"387","article-title":"Diindolylmethane (dim) spontaneously forms from indole-3-carbinol (i3c) during cell culture experiments","volume":"24","author":"Bradlow","year":"2010","journal-title":"In Vivo"},{"key":"10.1016\/j.phrs.2014.08.005_bib0195","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2141.2011.09007.x","article-title":"Burkitt lymphoma: the role of Epstein\u2013Barr virus revisited","volume":"156","author":"Gromminger","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1634\/theoncologist.2010-0213","article-title":"Epstein\u2013Barr virus-positive diffuse large b-cell lymphoma of the elderly: what we know so far","volume":"16","author":"Castillo","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.phrs.2014.08.005_bib0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semcancer.2009.07.002","article-title":"Epstein\u2013Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue","volume":"19","author":"Bornkamm","year":"2009","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0210","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1073\/pnas.93.19.10411","article-title":"C-myc activation renders proliferation of Epstein\u2013Barr virus (ebv)-transformed cells independent of ebv nuclear antigen 2 and latent membrane protein 1","volume":"93","author":"Polack","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.phrs.2014.08.005_bib0215","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ijc.1404","article-title":"Antagonistic effects of c-myc and Epstein\u2013Barr virus latent genes on the phenotype of human b cells","volume":"93","author":"Pajic","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.phrs.2014.08.005_bib0220","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2014.08.005_bib0225","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1093\/emboj\/cdf356","article-title":"C-flip(l) is a dual function regulator for caspase-8 activation and cd95-mediated apoptosis","volume":"21","author":"Chang","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.phrs.2014.08.005_bib0230","doi-asserted-by":"crossref","first-page":"45162","DOI":"10.1074\/jbc.M206882200","article-title":"The long form of flip is an activator of caspase-8 at the fas death-inducing signaling complex","volume":"277","author":"Micheau","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2014.08.005_bib0235","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature09852","article-title":"Catalytic activity of the caspase-8-flip(l) complex inhibits ripk3-dependent necrosis","volume":"471","author":"Oberst","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2014.08.005_bib0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/BJ20101738","article-title":"Flip(l) induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity","volume":"433","author":"Pop","year":"2011","journal-title":"Biochem J"},{"key":"10.1016\/j.phrs.2014.08.005_bib0245","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4049\/jimmunol.175.1.311","article-title":"Cellular flip long form augments caspase activity and death of t cells through heterodimerization with and activation of caspase-8","volume":"175","author":"Dohrman","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.phrs.2014.08.005_bib0250","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/BJ20040809","article-title":"Activation of caspases-8 and -10 by flip(l)","volume":"382","author":"Boatright","year":"2004","journal-title":"Biochem J"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181400142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181400142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T01:22:47Z","timestamp":1538270567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366181400142X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":50,"alternative-id":["S104366181400142X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2014.08.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718556050.793546253","asserted-by":"object"}]},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein\u2013Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2014.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}